Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 200.21M | 193.86M | 186.88M | 180.42M | 173.29M |
| Total Other Revenue | 1.40M | 1.30M | 1.47M | 1.20M | 1.24M |
| Total Revenue | 201.61M | 195.16M | 188.35M | 181.62M | 174.54M |
| Cost of Revenue | 64.87M | 64.10M | 62.27M | 60.51M | 57.64M |
| Gross Profit | 136.74M | 131.06M | 126.08M | 121.10M | 116.89M |
| SG&A Expenses | 103.86M | 94.50M | 91.73M | 88.63M | 80.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 195.46M | 183.95M | 177.44M | 170.96M | 158.09M |
| Operating Income | 6.16M | 11.21M | 10.91M | 10.66M | 16.45M |
| Income Before Tax | 7.39M | 7.11M | 7.28M | 5.52M | 11.48M |
| Income Tax Expenses | 3.47M | 2.47M | 1.93M | 1.72M | 2.23M |
| Earnings from Continuing Operations | 3.92 | 4.64 | 5.35 | 3.80 | 9.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.09M | -1.32M | -1.61M | -1.26M | -3.23M |
| Net Income | 2.82M | 3.33M | 3.74M | 2.54M | 6.03M |
| EBIT | 6.16M | 11.21M | 10.91M | 10.66M | 16.45M |
| EBITDA | 12.71M | 18.53M | 18.30M | 17.65M | 23.04M |
| EPS Basic | 0.03 | 0.04 | 0.04 | 0.03 | 0.07 |
| Normalized Basic EPS | 0.04 | 0.07 | 0.06 | 0.06 | 0.08 |
| EPS Diluted | 0.03 | 0.03 | 0.04 | 0.03 | 0.07 |
| Normalized Diluted EPS | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 |
| Average Basic Shares Outstanding | 368.16M | 362.17M | 357.01M | 353.84M | 353.20M |
| Average Diluted Shares Outstanding | 476.90M | 475.11M | 473.97M | 474.97M | 517.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |